Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Genes that mediate breast cancer metastasis to lung


By means of in vivo selection, transcriptomic analysis, functional verification and clinical validation, here we identify a set of genes that marks and mediates breast cancer metastasis to the lungs. Some of these genes serve dual functions, providing growth advantages both in the primary tumour and in the lung microenvironment. Others contribute to aggressive growth selectively in the lung. Many encode extracellular proteins and are of previously unknown relevance to cancer metastasis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: Selection of breast cancer cells metastatic to lung.
Figure 2: Gene-expression signature associated with lung metastasis.
Figure 3: Genes in the expression signature mediate lung metastasis.
Figure 4: Lung metastasis signature in human primary breast tumours.
Figure 5: Breast tumorigenicity and lung metastagenicity partially overlap.


  1. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563–572 (2002)

    Article  CAS  Google Scholar 

  2. Fidler, I. J. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nature Rev. Cancer 3, 453–458 (2003)

    Article  ADS  CAS  Google Scholar 

  3. Yokota, J. Tumor progression and metastasis. Carcinogenesis 21, 497–503 (2000)

    Article  CAS  Google Scholar 

  4. Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–549 (2003)

    Article  CAS  Google Scholar 

  5. Clark, E. A., Golub, T. R., Lander, E. S. & Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000)

    Article  ADS  CAS  Google Scholar 

  6. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 117, 927–939 (2004)

    Article  CAS  Google Scholar 

  7. Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002)

    Article  ADS  CAS  Google Scholar 

  8. van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002)

    Article  CAS  Google Scholar 

  9. van 't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002)

    Article  CAS  Google Scholar 

  10. Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003)

    Article  CAS  Google Scholar 

  11. Solomayer, E. F., Diel, I. J., Meyberg, G. C., Gollan, C. & Bastert, G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res. Treat. 59, 271–278 (2000)

    Article  CAS  Google Scholar 

  12. Cailleau, R., Olive, M. & Cruciger, Q. V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911–915 (1978)

    Article  CAS  Google Scholar 

  13. Minn, A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44–55 (2005)

    Article  CAS  Google Scholar 

  14. Shelly, M. et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem. 273, 10496–10505 (1998)

    Article  CAS  Google Scholar 

  15. Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127–137 (2001)

    Article  CAS  Google Scholar 

  16. Balkwill, F. Cancer and the chemokine network. Nature Rev. Cancer 4, 540–550 (2004)

    Article  CAS  Google Scholar 

  17. Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer 2, 161–174 (2002)

    Article  CAS  Google Scholar 

  18. Duffy, M. J., Maguire, T. M., Hill, A., McDermott, E. & O'Higgins, N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2, 252–257 (2000)

    Article  CAS  Google Scholar 

  19. Framson, P. E. & Sage, E. H. SPARC and tumour growth: where the seed meets the soil? J. Cell. Biochem. 92, 679–690 (2004)

    Article  CAS  Google Scholar 

  20. Wood, N. et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197, 703–709 (2003)

    Article  CAS  Google Scholar 

  21. Amatschek, S. et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumour-specific genes. Cancer Res. 64, 844–856 (2004)

    Article  CAS  Google Scholar 

  22. O'Hanlon, D. M. et al. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur. J. Cancer 38, 2252–2257 (2002)

    Article  CAS  Google Scholar 

  23. Desprez, P. Y., Sumida, T. & Coppe, J. P. Helix–loop–helix proteins in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 225–239 (2003)

    Article  Google Scholar 

  24. Ruzinova, M. B. & Benezra, R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13, 410–418 (2003)

    Article  CAS  Google Scholar 

  25. Arun, B. & Goss, P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin. Oncol. 31, 22–29 (2004)

    Article  CAS  Google Scholar 

  26. Beer, D. G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Med. 8, 816–824 (2002)

    Article  CAS  Google Scholar 

  27. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000)

    Article  ADS  CAS  Google Scholar 

  28. Simon, R. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br. J. Cancer 89, 1599–1604 (2003)

    Article  CAS  Google Scholar 

  29. Hynes, R. O. Metastatic potential: generic predisposition of the primary tumour or rare, metastatic variants-or both? Cell 113, 821–823 (2003)

    Article  CAS  Google Scholar 

  30. Heimann, R. & Hellman, S. Clinical progression of breast cancer malignant behaviour: what to expect and when to expect it. J. Clin. Oncol. 18, 591–599 (2000)

    Article  CAS  Google Scholar 

  31. Schairer, C., Mink, P. J., Carroll, L. & Devesa, S. S. Probabilities of death from breast cancer and other causes among female breast cancer patients. J. Natl. Cancer Inst. 96, 1311–1321 (2004)

    Article  Google Scholar 

  32. Davidson, B. et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumour progression. Clin. Cancer Res. 10, 7335–7346 (2004)

    Article  ADS  CAS  Google Scholar 

  33. Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740–751 (2004)

    Article  CAS  Google Scholar 

Download references


We thank R. Benezra, Y. Kang, C. Hudis, L. Norton, N. Rosen and C. VanPoznak for insights and discussions, and K. Manova and the staff of the Molecular Cytology Core Facility for assistance with immunohistochemistry. A.J.M is a recipient of the Leonard B. Holman Research Pathway fellowship. G.P.G. is supported by an NIH Medical Scientist Training Program grant, a fellowship from the Katherine Beineke Foundation and a Department of Defense Breast Cancer Research Program pre-doctoral traineeship award. J.M. is an Investigator of the Howard Hughes Medical Institute. This research is supported by the W.M. Keck Foundation and an NIH grant to J.M., and a US Army Medical Research grant to W.G.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Joan Massagué.

Ethics declarations

Competing interests

All microarray data have been submitted to the Gene Expression Omnibus (GEO) under accession number GSE2603. Reprints and permissions information is available at The authors declare no competing financial interests.

Supplementary information

Supplementary Figure S1

This figure shows validation of a Rosetta-type poor prognosis gene-expression signature and its uniform expression among MDA-MB-231 cell lines. It also demonstrates that the SCPs fall into distinct groups based on gene expression patterns, and exhibit distinct metastatic tropisms. (PDF 214 kb)

Supplementary Figure S2

Confirmation of protein expression for lung metastasis signature genes used in functional validation. (PDF 107 kb)

Supplementary Figure S3

Validation of combination transgenic parental MDA-MB-231 cell lines transduced with lung metastasis genes. (PDF 114 kb)

Supplementary Figure S4

This figure demonstrates that parental MDA-MB-231 cells overexpressing lung metastasis genes are not enhanced in bone metastatic activity. (PDF 441 kb)

Supplementary Figure S5

In this figure, linear combinations of each of the 54 lung metastasis genes weighted by either its estimated Cox model regression coefficient or a t-statistic derived from comparing its expression between LM2 cell lines with the parental MDA-MB-231 cell lines are used to distinguish patients at high risk of developing lung but not bone metastasis. (PDF 129 kb)

Supplementary Figure S6

This figure identifies a subgroup of primary breast cancers that express the lung metastasis signature in the Rosetta data set using hierarchical clustering. (PDF 2056 kb)

Supplementary Figure S7

This figure demonstrates K-means clustering and comparison to LM2 gene expression centroids for primary breast cancers in the Rosetta data set. These methods are used to identify tumours that express the lung metastasis signature, which is used in class prediction training. (PDF 415 kb)

Supplementary Figure Legends

Descriptions of data presented in Supplementary Figures S1-S7. (DOC 32 kb)

Supplementary Tables

All supplementary tables referenced to in the text are included in this file. They include information on cell lines used in the study, as well as several gene lists that are derived in the course of the work. (DOC 216 kb)

Supplementary Data S1

This file contains a pivot table for the Affymetrix U133A gene expression data for all cell lines used in the study. (XLS 14613 kb)

Supplementary Data S2

This file contains an Affymetrix U133A pivot table for gene expression analysis of primary breast cancers in the MSKCC cohort. (XLS 14369 kb)

Supplementary Data S3

This file contains clinical annotations, gene lists, and results of class assignments and predictions utilized in Figure 4 of the main paper. (XLS 293 kb)

Supplementary Methods S1

Description of additional experimental procedures that was not included in the main text due to constraints on space. (DOC 34 kb)

Supplementary Methods S2

Detailed description of analytical methods used in the paper, including derivation of gene lists and class prediction algorithms. (DOC 102 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Minn, A., Gupta, G., Siegel, P. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing